癌症进展中的综合应激反应:塑性和耐药性的力量
Caleb L Lines1, Morgan J McGrath1, Tanis Dorwart1
1Department of Radiation Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States.
Frontiers in oncology
|August 21, 2023
概括
癌细胞劫持综合应激反应 (ISR) 来控制蛋白质合成,促进生长和治疗耐药性. 针对ISR提供了癌症治疗的潜在新策略.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 细胞应激反应的应激反应
背景情况:
- 癌细胞操纵细胞机制,以创造一个支持性瘤微环境.
- 失控的增殖是由增强的合成过程,如蛋白质合成.
- 癌细胞通过转化控制改变基因表达来适应瘤性压力.
研究的目的:
- 研究综合应激反应 (ISR) 信号在推动癌症进展中的作用.
- 阐明ISR下游的mRNA翻译调节机制.
- 了解瘤信号如何利用ISR来应对环境压力和治疗阻力.
主要方法:
- 对癌细胞中综合应激反应 (ISR) 信号通路的分析.
- 在瘤性压力下对mRNA翻译调节机制的研究.
- 对癌细胞可塑性和治疗耐药性的检查,与ISR活性相关.
主要成果:
- 综合应激反应 (ISR) 被瘤性压力激活,以微调蛋白质合成.
- 通过ISR信号重新连接蛋白质组,将平衡转向生长和适应,促进生存.
- ISR信号传递有助于癌细胞的可塑性和治疗耐药性的发展.
结论:
- 综合应激反应 (ISR) 在癌症的进展和生存中发挥着关键作用.
- 调节ISR活动为开发新型癌症疗法提供了一个有希望的途径.
- 针对ISR可能提供一种独特的策略,以克服癌症治疗中的治疗耐药性.
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
47
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
47
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


